Yoga Nidra for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Yoga Nidra for Health & Longevity

Created on 07/14/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A free, equipment-free guided relaxation practice that brings the body to the edge of sleep while staying aware. Strongest evidence is for calming the stress response, lowering stress hormones, easing anxiety, improving sleep, and modestly lowering blood pressure. One of the safest tools available; effects on mood and pain are more modest and studies are low quality. (Full Review)

Protocol

Session Format
20–45 min
Lying down (savasana) in a quiet, dimly lit space, following a guided audio track
Frequency
Daily
Daily or near-daily; cumulative benefits assessed over an 8-week course
Best Time
Afternoon or bedtime
Afternoon for recovery; bedtime to initiate or return to sleep
Time to effect
Acute Relaxation
First session
Calmer state measurable within a single 11–30 min session
Sleep & Mood
4–8 weeks
Cumulative improvements in sleep, mood, and stress
Blood Pressure
8 weeks
Reduction assessed over an 8-week course of regular practice

Benefits

Contraindications
  • Active psychosis, acute mania, or severe untreated dissociative disorder (avoid unsupervised practice)
  • Active PTSD or recent significant trauma (use trauma-informed instruction)
  • Never practice while driving or operating machinery
    •
Key Interactions
  • Antihypertensive medications (lisinopril, amlodipine, losartan)
  • Sedatives, hypnotics & sleep aids (benzodiazepines, Z-drugs, sedating antihistamines)
  • Glucose-lowering agents (insulin, sulfonylureas)
  • Sedating OTC agents (diphenhydramine, doxylamine, melatonin)
    •

Risk & Side Effects

  • High: Daytime drowsiness & unintended sleep
    •
  • Medium: Emotional discomfort or distress during practice
    •
  • Low: Meditation-related adverse effects; post-practice light-headedness & transient hypotension; deferral of needed medical care
    •
  • Speculative: Destabilization in psychosis-prone individuals; over-reliance on guided audio
    •

Monitoring

Marker Target Why
Resting blood pressure ~110–120 / 70–78 mmHg Primary objective target for the practice's cardiovascular effect
Resting heart rate 55–70 beats/min Reflects parasympathetic tone and recovery
Heart rate variability (rMSSD) Higher is better; track personal trend Sensitive marker of autonomic balance and stress resilience
Morning cortisol / cortisol awakening response Robust morning peak with a healthy daytime decline Direct readout of stress-axis regulation
Fasting glucose / HbA1c Fasting 75–90 mg/dL; HbA1c <5.4% Captures any metabolic benefit from stress reduction
hs-CRP <1.0 mg/L Tracks low-grade inflammation linked to chronic stress and aging

Cadence: Baseline, 4 weeks, 8–12 weeks, then every 3–6 months; blood pressure and subjective measures weekly during the first month

Qualitative Assessment

  • Sleep quality: ease of falling asleep, night waking, and feeling rested (optionally scored with the PSQI)
  • Perceived stress and mood: day-to-day calm, irritability, and anxiety levels
  • Daytime energy and the afternoon slump: whether midday sessions restore alertness
  • Cognitive clarity and focus: subjective concentration and mental freshness after practice
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.